Valeant Pharmaceuticals reported $1.37B in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Amgen AMGN:US $ 4677M 451M
Ani Pharmaceuticals ANIP:US $ 30.21M 3.18M
Aurora Cannabis Inc ACB:CN -52930000 16.56M
Biogen BIIB:US $ 1777.9M 295.8M
Bristol Myers Squibb BMY:US $ 9177M 452M
Canopy Growth Corp WEED:CN C$ -159242000 169.33M
Catalent CTLT:US $ 423M 18M
Corcept Therapeutics CORT:US $ 92.44M 5.03M
Danaher DHR:US $ 4705M 238M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Endo International Ordinary Shares ENDP:US $ 472.5M 94.46M
Gilead Sciences GILD:US $ 5166M 549M
Horizon Pharma HZNP:US $ 670.18M 102.77M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Lannett LCI:US $ 3.08M 2.63M
Nektar Therapeutics NKTR:US $ 19.51M 0.66M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Perrigo Ordinary Shares PRGO:US $ 337.8M 24.6M
Phibro Animal Health PAHC:US $ 71.63M 0.95M
Prestige Brands PBH:US $ 148.86M 6.2M
Revance Therapeutics RVNC:US $ 17.37M 701K
Supernus Pharmaceuticals SUPN:US $ 134.57M 7.48M
Valeant Pharmaceuticals VRX:CN $ 1367M 203M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
Zoetis ZTS:US $ 1421M 50M